After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

What are the symptoms of emphysema? - Understanding the condition is the first step towards taking control of your lung ...

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

Verona Pharma stock hit a record high Thursday on continued enthusiasm for its newly launched COPD treatment, Ohtuvayre.

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

New Study Shows Promising Results for COPD Treatment Nov. 20 ... molecule is as sneaky as its inventors ... COPD and BPD: Inhalation of Live Lactobacilli Lessens Lung Inflammation and Improves ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Chief executive David Zaccardelli said Ohtuvayre was off to an "exceptionally strong start," with more than 3,500 healthcare ...

UK pharma major AstraZeneca’s Fasenra (benralizumab), with its highly anticipated Phase III data to be showcased at the 2025 ...